Solasonine

CAS No. 19121-58-5

Solasonine( —— )

Catalog No. M18170 CAS No. 19121-58-5

The equimolar mixture Solamargine/Solasonine was the most active (IC50: 1.1?μM) after 72?h.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 72 In Stock
10MG 115 In Stock
25MG 201 In Stock
50MG 300 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Solasonine
  • Note
    Research use only, not for human use.
  • Brief Description
    The equimolar mixture Solamargine/Solasonine was the most active (IC50: 1.1?μM) after 72?h.
  • Description
    The equimolar mixture Solamargine/Solasonine was the most active (IC50: 1.1?μM) after 72?h.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    19121-58-5
  • Formula Weight
    884.07
  • Molecular Formula
    C45H73NO16
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (113.11 mM)
  • SMILES
    [C@@H]1([C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O[C@H]1[C@H]([C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@@H]5O[C@]6([C@H]([C@@H]5[C@]4(CC[C@@H]3[C@]2(CC1)C)C)C)NC[C@@H](CC6)C)CO)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fewell AM, et al. Interactions between the glycoalkaloids solasonine and solamargine in relation to inhibition of fungal growth. Phytochemistry. 1994 Nov;37(4):1007-11.
molnova catalog
related products
  • Astrasieversianin VI...

    Isoastragaloside II is a derivative Astragaloside I, an ingredient in Astragalus membranaceus which is reported to have osteogenic properties.

  • Cys-TAT(47-57)

    Cys-TAT(47-57) (Cys-[HIV-Tat (47-57)]) is an arginine rich cell penetrating peptide derived from the HIV-1 transactivating protein.This peptide corresponds to the protein transduction domain of the TAT protein.

  • BNM-III-170

    BNM-III-170 is a small-molecule CD4-mimetic compound that enhances vaccine efficacy against HIV-1 challenge in vivo.